Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Mar 18:9:175.
doi: 10.1186/s13104-016-1975-9.

Barraquer-Simons syndrome: a rare form of acquired lipodystrophy

Affiliations
Case Reports

Barraquer-Simons syndrome: a rare form of acquired lipodystrophy

Joana Oliveira et al. BMC Res Notes. .

Abstract

Background: Human lipodystrophies are uncommon disorders, with important clinical consequences, which are often undiagnosed. The Barraquer-Simons syndrome is a form of partial symmetric lipodystrophy of unknown etiology, characterized by the loss of subcutaneous adipose tissue, limited to upper part of the body. Insulin resistance and metabolic complications are less common than with other lipodystrophy subtypes. Patients usually have decreased serum complement-component 3 levels, associated with complement activation by the alternative pathway, which may indicate the presence of renal involvement.

Case presentation: The authors report a case of a 31-year-old woman with progressive loss of subcutaneous fat, limited to the face, neck and thorax. She presented no severe metabolic complications, neither signs of insulin resistance. Laboratory tests revealed mild dyslipidemia, and low serum levels of complement-component 3. Clinical and biochemical characteristics were consistent with the diagnosis of Barraquer-Simons syndrome.

Conclusion: The present case illustrates the importance of recognizing the clinical features of this lipodystrophic syndrome, which may present potentially severe consequences and psychological distress. A brief overview is made, addressing the clinical signs of the disease, its course, and how to manage it.

Keywords: Acquired partial lipodystrophy; Adipose tissue; Barraquer–Simons syndrome; Cephalothoracic lipodystrophy; Hypocomplementemia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Progressive facial lipoatrophy with loss of buccal fat pads
Fig. 2
Fig. 2
Subcutaneous adipose tissue preserved in the lower abdomen and thighs

References

    1. Capeau J, Magre J, Caron-Debarle M, et al. Human lipodystrophies: genetic and acquired diseases of adipose tissue. Endocr Dev. 2010;19:1–20. doi: 10.1159/000316893. - DOI - PMC - PubMed
    1. Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96(11):3313–3325. doi: 10.1210/jc.2011-1159. - DOI - PMC - PubMed
    1. Nolis T. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. J Hum Genet. 2013;59(1):16–23. doi: 10.1038/jhg.2013.107. - DOI - PubMed
    1. Gavrilova O, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest. 2000;105:271–278. doi: 10.1172/JCI7901. - DOI - PMC - PubMed
    1. Reitman ML, Arioglu E, Gavrilova O, et al. Lipoatrophy revisited. Trends Endocrinol Metab. 2000;11:410–416. doi: 10.1016/S1043-2760(00)00309-X. - DOI - PubMed

Publication types

Supplementary concepts

LinkOut - more resources